5I33
Unligated adenylosuccinate synthetase from Cryptococcus neoformans
5I33 の概要
| エントリーDOI | 10.2210/pdb5i33/pdb |
| 関連するPDBエントリー | 5I34 |
| 分子名称 | Adenylosuccinate synthetase (2 entities in total) |
| 機能のキーワード | dimer, adenylosuccinate synthetase, purine metabolism, ligase |
| 由来する生物種 | Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) |
| 細胞内の位置 | Cytoplasm : J9VI09 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 95878.94 |
| 構造登録者 | Blundell, R.D.,Williams, S.J.,Ericsson, D.,Fraser, J.A.,Kobe, B. (登録日: 2016-02-09, 公開日: 2016-08-24, 最終更新日: 2023-09-27) |
| 主引用文献 | Blundell, R.D.,Williams, S.J.,Arras, S.D.,Chitty, J.L.,Blake, K.L.,Ericsson, D.J.,Tibrewal, N.,Rohr, J.,Koh, Y.Q.,Kappler, U.,Robertson, A.A.,Butler, M.S.,Cooper, M.A.,Kobe, B.,Fraser, J.A. Disruption of de Novo Adenosine Triphosphate (ATP) Biosynthesis Abolishes Virulence in Cryptococcus neoformans. Acs Infect Dis., 2:651-663, 2016 Cited by PubMed Abstract: Opportunistic fungal pathogens such as Cryptococcus neoformans are a growing cause of morbidity and mortality among immunocompromised populations worldwide. To address the current paucity of antifungal therapeutic agents, further research into fungal-specific drug targets is required. Adenylosuccinate synthetase (AdSS) is a crucial enzyme in the adeosine triphosphate (ATP) biosynthetic pathway, catalyzing the formation of adenylosuccinate from inosine monophosphate and aspartate. We have investigated the potential of this enzyme as an antifungal drug target, finding that loss of function results in adenine auxotrophy in C. neoformans, as well as complete loss of virulence in a murine model. Cryptococcal AdSS was expressed and purified in Escherichia coli and the enzyme's crystal structure determined, the first example of a structure of this enzyme from fungi. Together with enzyme kinetic studies, this structural information enabled comparison of the fungal enzyme with the human orthologue and revealed species-specific differences potentially exploitable via rational drug design. These results validate AdSS as a promising antifungal drug target and lay a foundation for future in silico and in vitro screens for novel antifungal compounds. PubMed: 27759389DOI: 10.1021/acsinfecdis.6b00121 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.2 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






